Breaking News

You are here » Indian-Commodity  :  Economy  :  India's pharma exports declined by 4% till August on pricing pressure


India's pharma exports declined by 4% till August on pricing pressure

India's pharmaceutical exports has registered a negative growth of 4 percent during the first five months of the financial year 2017-18, mainly due to increased regulatory issues along with pricing pressure in global markets. Udaya Bhaskar, the Director General of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), has said that the pharma exports to other countries declined by 7.9 percent during the April-July period, while recovered to 4 percent in the month of August leaving the overall growth at minus 4 percent till August this year.

Bhaskar has pointed out that pricing pressure is one of the factors for decline in exports. He also noted that factors such as import alerts by US Food and Drug Administration (USFDA) on Indian plants, regulatory issues and currency fluctuation, also contributed to downward growth. However, he hoped that the overall exports will recover and come into positive zone for the full year as exports are expected to take an uptick from September.

Pharmexcil's Director General further said that initially, rollout of Goods and Services Tax (GST) regime also created some confusion among the manufacturers leading to stoppage of production by some companies, but now they are seeing some growth. According to statistics, India exported $16.90 billion worth of pharma products during 2015-16 and the same was slightly declined to $16.64 billion in 2016-17.

Related News

View all news

Number of people filing tax returns may double during 5 years of present government: Jaitley

Finance Minister Arun Jaitley has said that the number of people filing tax returns in India is likely to double to 7.6 crore during 5 years of present government due to initiatives like rationalisation......

Cabinet may soon approve proposed new industrial policy: Prabhu

Commerce and Industry Minister Suresh Prabhu has said the Union Cabinet may soon approve the new industrial policy that aims at promoting manufacturing, attracting investments and creating jobs. He also......

India's manufacturing sector outlook to remain positive for Q2FY19: FICCI

With higher production in manufacturing, Federation of Indian Chambers of Commerce and Industry (FICCI) in its latest quarterly survey has stated that the outlook for India's manufacturing sector is positive......

Top News

View all news

Hero MotoCorp achieves best ever sales performance in Q2 FY19

Hero MotoCorp has achieved its best-ever sales performance for the second quarter of any financial year, selling 21,34,051 units of two-wheelers in Q2 FY19.For the period April-September 2018, Hero MotoCorp......

Mahindra CIE Automotive reports 74% rise in Q3 net profit

Mahindra CIE Automotive has reported results for third quarter ended September 30, 2018.The company has reported 73.80% rise in its net profit at Rs 42.58 crore for the quarter under review as compared......

Infosys crosses $2 billion large deal signings in Q2 FY19

Infosys has crossed $2 billion large deal signings in Q2 FY19. Besides, the company's digital revenues stood at $905 million in Q2 FY19 (31.0% of total revenues), year-on-year growth of 33.5% and sequential......